Catalyst Pharmaceuticals, Inc.

MetLife Investment Management, LLC CPRX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

594,073

Value ($000)

13,866

Weight

0.1%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	13,866	0.1%	594,073	12/31/2025
2025 Q3	11/13/2025	14,571	0.1%	739,668	9/30/2025
2025 Q2	8/13/2025	12,645	0.1%	582,721	6/30/2025
2025 Q1	5/14/2025	17,559	0.1%	724,091	3/31/2025
2024 Q4	2/13/2025	1,421	0.0%	68,087	12/31/2024
2024 Q3	11/13/2024	1,266	0.0%	63,674	9/30/2024
2024 Q2	8/13/2024	1,043	0.0%	67,337	6/30/2024
2024 Q1	5/14/2024	909	0.0%	57,014	3/31/2024
2023 Q4	4/22/2024	877	0.0%	52,200	12/31/2023
2023 Q3	5/9/2024	610	0.0%	52,200	9/30/2023
2023 Q2	4/29/2024	702	0.0%	52,200	6/30/2023
2023 Q1	5/9/2024	837	0.0%	50,484	3/31/2023
2022 Q4	5/10/2024	939	0.0%	50,484	12/31/2022
2022 Q3	5/10/2024	681	0.0%	53,094	9/30/2022
2022 Q2	5/10/2024	372	0.0%	53,094	6/30/2022
2022 Q1	5/10/2024	409	0.0%	49,347	3/31/2022
2021 Q4	5/17/2024	239	0.0%	35,330	12/31/2021
2021 Q3	5/17/2024	136	0.0%	25,698	9/30/2021
2021 Q2	5/17/2024	243	0.0%	42,220	6/30/2021
2021 Q1	5/17/2024	195	0.0%	42,220	3/31/2021
2020 Q4	5/24/2024	56	0.0%	16,768	12/31/2020
2020 Q3	5/24/2024	59	0.0%	19,806	9/30/2020
2020 Q2	5/24/2024	212	0.0%	45,807	6/30/2020
2020 Q1	7/12/2023	176	0.0%	45,807	3/31/2020
2019 Q4	7/12/2023	95	0.0%	25,312	12/31/2019
2019 Q3	7/12/2023	261	0.0%	49,243	9/30/2019
2019 Q2	7/12/2023	189	0.0%	49,243	6/30/2019
2019 Q1	7/13/2023	251	0.0%	49,243	3/31/2019
2018 Q4	7/13/2023	95	0.0%	49,243	12/31/2018
2018 Q3	7/13/2023	186	0.0%	49,243	9/30/2018